Skip to content

13F-HR filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 60 holding rows worth $840,509,000.

Accession
0001697013-21-000002
Filed
2021-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 60 entries on the cover page, a total value of $840,509,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $840,509,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMARIN CORP PLC023111206SPONS ADR NEW15,943,915$77,966,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock458,636$69,616,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM376,200$58,777,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock863,851$44,938,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR852,431$42,613,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS530,976$38,841,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM399,499$36,326,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR946,581$35,197,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR187,043$31,195,000thousands by filing date
CATALENT INC USD 0.01148806102COM279,503$29,088,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM861,355$29,054,000thousands by filing date
Danaher Corporation235851102COM126,330$28,082,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR2,748,250$26,521,000thousands by filing date
AVANTOR INC COM05352A100Stock920,650$25,916,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM138,644$23,637,000thousands by filing date
Elevance Health, Inc.036752103COM65,771$21,118,000thousands by filing date
ZOGENIX INC.98978L204Common Stock909,708$18,185,000thousands by filing date
QIAGEN NVN72482123SHS NEW336,862$17,803,000thousands by filing date
ENSIGN GROUP INC29358P101COM208,470$15,214,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM246,240$14,053,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK356,235$11,328,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS152,256$11,179,000thousands by filing date
HESKA CORP42805E306COM76,166$11,094,000thousands by filing date
KADMON HLDGS INC48283N106COM2,408,885$9,997,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM103,764$8,894,000thousands by filing date
MAGELLAN HEALTH SERVICES INC559079207COM NEW104,700$8,673,000thousands by filing date
RITE AID CORP767754872COM532,004$8,422,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock604,368$8,358,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM334,049$8,184,000thousands by filing date
GLAXOSMITHKLINE PLC-SPON ADR37733W905COM3,526$7,369,000thousands by filing date
QUIDEL CORP74838J101COM40,583$7,291,000thousands by filing date
AFFIMED N VN01045108COM964,707$5,615,000thousands by filing date
AMNEAL PHARMACEUTICALS INC03168L105COM STK CL A1,178,153$5,384,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS307,742$5,375,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW380,000$4,286,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock491,852$3,664,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock209,155$3,558,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR68,138$3,311,000thousands by filing date
HCA Healthcare Inc40412C101COM16,754$2,755,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock203,328$2,442,000thousands by filing date
SESEN BIO INC817763105COM1,559,824$2,106,000thousands by filing date
ANAPTYSBIO INC032724106COM88,334$1,899,000thousands by filing date
Surmodics Inc868873100Common Stock41,299$1,797,000thousands by filing date
ONCTERNAL THERAPEUTICS INC68236P107COM344,090$1,686,000thousands by filing date
OTONOMY INC68906L105COM253,283$1,639,000thousands by filing date
AUTOLUS THERAPEUTICS PLC SPON05280R100COM154,981$1,386,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM103,829$1,312,000thousands by filing date
CATABASIS PHARMACEUTICALS IN14875P206COM NEW522,042$1,117,000thousands by filing date
EXAGEN INC30068X103COM81,603$1,077,000thousands by filing date
DEXCOM INC COM252131107Stock2,473$914,000thousands by filing date
PROTARA THERAPEUTICS INC74365U107COM STK36,310$879,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock4,085$732,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock4,977$590,000thousands by filing date
AMARIN CORPORATION PLC -ADR023111906ADR12,854$471,000thousands by filing date
GOHEALTH INC38046W105COM CL A29,685$405,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM18,925$359,000thousands by filing date
ZYMEWORKS INC98985W102COM5,405$255,000thousands by filing date
MERUS N VN5749R100COM14,445$253,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM3,816$218,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK12,805$95,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-21-000002this filing2021-02-16acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000019 base2023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000020 added2023-11-08acceptance time not in the bulk data set